Anti-ALK antibody [5A4] (ab17127)

ab17127 has been referenced in 11 publications.

• Tartarone A  et al. Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancer. J Thorac Dis 9:S1359-S1363 (2017). PubMed: 29184674
• Manicone M  et al. Liquid biopsy for monitoring anaplastic lymphoma kinase inhibitors in non-small cell lung cancer: two cases compared. J Thorac Dis 9:S1391-S1396 (2017). PubMed: 29184678
• Hazkani I  et al. Can molecular profiling enhance radiotherapy? Impact of personalized targeted gold nanoparticles on radiosensitivity and imaging of adenoid cystic carcinoma. Theranostics 7:3962-3971 (2017). PubMed: 29109791
• Duruisseaux M  et al. Pro-tumoural CXCL10/CXCR3-A autocrine loop in invasive mucinous lung adenocarcinoma. ERJ Open Res 3:N/A (2017). PubMed: 28845427
• Furukawa M  et al. Genetic alterations in lung adenocarcinoma with a micropapillary component. Mol Clin Oncol 4:195-200 (2016). PubMed: 26893860
• Le Quesne J  et al. A comparison of immunohistochemical assays and FISH in detecting the ALK translocation in diagnostic histological and cytological lung tumor material. J Thorac Oncol 9:769-74 (2014). PubMed: 24787965
• Ferretti GR  et al. Adequacy of CT-guided biopsies with histomolecular subtyping of pulmonary adenocarcinomas: Influence of ATS/ERS/IASLC guidelines. Lung Cancer 82:69-75 (2013). PubMed: 23927885
• Lopes LF & Bacchi CE Anaplastic lymphoma kinase gene rearrangement in non-small-cell lung cancer in a Brazilian population. Clinics (Sao Paulo) 67:845-7 (2012). IHC . PubMed: 22892933
• Kijima T  et al. Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancer. Cancer Sci 102:1602-4 (2011). IHC ; Human . PubMed: 21767331
• Sasaki T  et al. A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors. Cancer Res 71:6051-60 (2011). IHC-P ; Human . PubMed: 21791641
• Jokoji R  et al. Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma. J Clin Pathol 63:1066-70 (2010). IHC-P ; Human . PubMed: 20935334